Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.008Source: DataRank Database

Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies is a research paper published in Clinical Lymphoma Myeloma & Leukemia (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (18)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

David M. Margolis ORCID,Daniel J. Landsburg ORCID,Emily C. Ayers ORCID

Live enrichment

PubMed:32576502 PMC:PMC8075299

NCI NIH HHS

Grant: T32 CA009679

National Institutes of Health

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8075299

publisherhttps://api.elsevier.com/content/article/PII:S2152265020302366?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2152265020302366?httpAccept=text/plain

MeSH Terms

HumansRecurrenceTreatment OutcomeRetrospective StudiesAdolescentAdultAgedAged, 80 and overMiddle AgedFemaleMaleLymphoma, Large B-Cell, DiffuseYoung Adult

Keywords

ChemotherapySalvage therapyNon-hodgkin LymphomaLenalidomideNon-curative Intent Therapy

Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies

FAIR Checklist

Authors (3)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)